Patent Eligibility as a Policy Lever to Regulate the Patenting of Personalized Medicine

被引：0
|
作者：
Holman, Christopher M. [1 ]
机构：
[1] Univ Missouri Kansas City, Sch Law, Law, Kansas City, MO 64110 USA
来源：
PERSPECTIVES ON PATENTABLE SUBJECT MATTER | 2015年
关键词：
BILSKI;
D O I：
暂无
中图分类号：
D9 [法律]; DF [法律];
学科分类号：
0301 ;
摘要：
引用
收藏
页码：114 / 150
页数：37
相关论文
共 47 条
  • [31] Patenting Standards - A Case for US Antitrust Law or a Call for Recognizing Immanent Public Policy Limitations to the Exploitation Rights Conferred by the Patent Act?
    Chronopoulos, Apostolos
    IIC-INTERNATIONAL REVIEW OF INTELLECTUAL PROPERTY AND COMPETITION LAW, 2009, 40 (07) : 782 - 816
  • [32] MICROSIMULATION METHODS USED FOR HEALTH POLICY DECISIONS IN PERSONALIZED MEDICINE UNDER CONSTRAINED RESOURCES
    Jahn, B.
    Rochau, U.
    Muehlberger, N.
    Sroczynski, G.
    Conrads-Frank, A.
    Siebert, U.
    VALUE IN HEALTH, 2011, 14 (07) : A424 - A425
  • [33] Personalized medicine in women's obesity prevention and treatment: implications for research, policy and practice
    Yang, N.
    Ginsburg, G. S.
    Simmons, L. A.
    OBESITY REVIEWS, 2013, 14 (02) : 145 - 161
  • [34] WHEN AND HOW ARE EVIDENCE REVIEWS ON PERSONALIZED MEDICINE USED FOR HEALTH PLAN POLICY DECISIONS?
    Van Bebber, S. L.
    Trosman, J.
    Phillips, K. A.
    VALUE IN HEALTH, 2010, 13 (03) : A97 - A97
  • [35] Response of patent medicine vendors in rural areas of Lagos state Nigeria to antimalarial policy change
    Oyeyemi, Abisoye
    Ogunnowo, Babatunde
    Odukoya, Oluwakemi
    AFRICAN HEALTH SCIENCES, 2015, 15 (02) : 420 - 428
  • [36] The Genetic Information Nondiscrimination Act (GINA): Public Policy and Medical Practice in the Age of Personalized Medicine
    Eric A. Feldman
    Journal of General Internal Medicine, 2012, 27 : 743 - 746
  • [37] The Genetic Information Nondiscrimination Act (GINA): Public Policy and Medical Practice in the Age of Personalized Medicine
    Feldman, Eric A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 (06) : 743 - 746
  • [38] Initial development of an evidence base for personalized medicine's translation to clinical practice and health policy
    Phillips, Kathryn A.
    Van Bebber, Stephanie L.
    Issa, Amalia M.
    PERSONALIZED MEDICINE, 2006, 3 (04) : 411 - 414
  • [39] Scaling training facilities for patent and proprietary medicine vendors in Nigeria: insights and lessons learned for policy implication and future partnerships
    Okafor, Emeka
    Idogho, Omokhudu
    Anyanti, Jennifer
    Yusuf, Dayyabu
    Diallo, Rodio
    Alagbile, Michael
    Wada, Yusuf H.
    HEALTH RESEARCH POLICY AND SYSTEMS, 2024, 22 (01):
  • [40] Coactive Preference-Guided Multi-Objective Bayesian Optimization: An Application to Policy Learning in Personalized Plasma Medicine
    Shao, Ketong
    Chakrabarty, Ankush
    Mesbah, Ali
    Romeres, Diego
    IEEE Control Systems Letters, 2024, 8 : 3081 - 3086
12345